Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

AstraZeneca is under scrutiny in China — as its top executive there and other personnel are being investigated by authorities ...

(Reuters) - Americans are still eagerly seeking prescriptions for Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO)'s weight-loss and diabetes drugs but ... to get off the FDA shortage list without ...

Analysis-Americans Hungry for Weight-Loss ... off the FDA shortage list without fully resolving the supply issue, seeking to stop compounders from making copycat versions of their drugs.

We’ll help fill some of the gaps, including which FDA-approved diabetes drugs can cause weight loss, how effective they are at reducing and managing body weight, and the possible side effects.

Plot twist: These trendy weight loss medications aren’t like your regular pills. Many require specific storage conditions, including refrigeration, to stay safe and effective. When you buy ...

But now, a new study in The New England Journal of Medicine shows that they may want to consider a self-injection option – of the weight loss drug semaglutide ... and the FDA has also approved ...